CHINA SXT PHARMACEUTICALS IN's ticker is SXTC and the CUSIP is G2161P108. A total of 7 filers reported holding CHINA SXT PHARMACEUTICALS IN in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $546,000 | -52.9% | 2,228,517 | +1.3% | 0.01% | -60.0% |
| Q2 2020 | $1,160,000 | -3.7% | 2,200,766 | +2.4% | 0.02% | -33.3% |
| Q1 2020 | $1,204,000 | -25.3% | 2,149,187 | +7.5% | 0.03% | -16.7% |
| Q4 2019 | $1,611,000 | -36.3% | 2,000,000 | -1.7% | 0.04% | -48.6% |
| Q3 2019 | $2,531,000 | -62.8% | 2,033,704 | +1.7% | 0.07% | -55.1% |
| Q2 2019 | $6,802,000 | – | 2,000,000 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hudock, Inc. | 7,500 | $2,000 | 0.00% |
| UBS Group AG | 55,184 | $18,000 | 0.00% |
| FIFTH THIRD BANCORP | 1,000 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 106,568 | $35,000 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 36,886 | $12,000 | 0.00% |
| Renaissance Technologies | 664,647 | $218,000 | 0.00% |